PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-48	Closed	-$1.86K	–	561
2025 Q3	$1.86K	Sell	48 -1	-2%	-$36	﹤0.01%	486
2025 Q2	$1.64K	Hold	49	–	–	﹤0.01%	438
2025 Q1	$1.54K	Sell	49 -47	-49%	-$1.78K	﹤0.01%	420
2024 Q4	$3.73K	Buy	+96	New	+$4.03K	﹤0.01%	408

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s GNOM Position: Q4 2025 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2025, closing a stake of 48 shares — an estimated $1.86K sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in GNOM in Q4 2024 and held it in 4 quarters. The position peaked at $3.73K in Q4 2024. 40 funds tracked by Wall St. Rank hold GNOM as of Q4 2025.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 48 Global X Genomics & Biotechnology ETF shares in Q4 2025, an estimated $1.86K.
PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in Global X Genomics & Biotechnology ETF in Q4 2024 and held it in 4 quarters.
PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s Global X Genomics & Biotechnology ETF position peaked at $3.73K in Q4 2024.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2025.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q4 2025, filed 7 Aug 2026.